Medicare Enrolled
Dr. Bilal Farooqi, MD
Hematology & Oncology · Suffern, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Farooqi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Farooqi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Farooqi
Dr. Bilal Farooqi is a hematology & oncology specialist in Suffern, NY, with 13 years of NPI registration. Based on federal Medicare data, Dr. Farooqi performed 7,572 Medicare services across 1,400 unique beneficiaries.
Between the years covered by Open Payments, Dr. Farooqi received a total of $5,385 from 42 pharmaceutical and/or device companies across 144 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Farooqi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 22% volume in NY
$5,385 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,572
Medicare services
Top 22% in NY for hematology & oncology
1,400
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~582 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
4,800 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
359 | $8 | $15 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
333 | $8 | $32 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
273 | $9 | $38 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
264 | $10 | $40 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
229 | $104 | $274 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
172 | $6 | $25 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
124 | $13 | $56 |
| Iron level test | 124 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
124 | $9 | $36 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
121 | $17 | $52 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
93 | $158 | $366 |
| Serum protein measurement A blood test that measures the total amount of protein in the serum. It helps evaluate overall health and nutritional status. |
82 | $11 | $36 |
| Serum immunofixation test A laboratory test that analyzes a blood serum sample to identify specific abnormal proteins. The procedure uses an immunologic technique to detect and characterize these proteins. |
82 | $22 | $75 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
70 | $143 | $412 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
41 | $61 | $240 |
| Total protein blood test A blood test that measures the total amount of protein in your blood. This test helps evaluate your overall health and nutritional status. |
40 | $4 | $15 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
30 | $11 | $72 |
| Haptoglobin level test A blood test that measures the amount of haptoglobin, a protein in the serum. It helps evaluate red blood cell breakdown. |
29 | $12 | $52 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
25 | $18 | $74 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
21 | $15 | $62 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
21 | $14 | $61 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
19 | $77 | $188 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
18 | $4 | $17 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
17 | $3 | $12 |
| PSA test (prostate cancer screening) | 14 | $18 | $76 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
13 | $16 | $69 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
12 | $4 | $17 |
| Immunoassay substance analysis, multiple step method A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material. |
11 | $11 | $45 |
| Autoimmune disorder screening test A laboratory test used to screen for the presence of autoimmune disorders. |
11 | $12 | $41 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
63.8% medium
35.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,385
Total received (2018-2024)
Avg $769/year across 7 years
Top 34% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
144
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,776 (51.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,695 (31.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$914 (17.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$532
2023
$153
2022
$703
2021
$75
2020
$2,515
2019
$1,115
2018
$292
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$136
W. L. Gore & Associates, Inc.
$125
Incyte Corporation
$95
BeiGene USA, Inc.
$70
Lilly USA, LLC
$47
Adaptive Biotechnologies Corporation
$30
Novartis Pharmaceuticals Corporation
$30
Top 3 companies account for 66.9% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$1,853
AstraZeneca Pharmaceuticals LP
$671
Lilly USA, LLC
$282
Janssen Biotech, Inc.
$274
Incyte Corporation
$243
Astellas Pharma US Inc
$210
Novartis Pharmaceuticals Corporation
$193
Daiichi Sankyo Inc.
$128
W. L. Gore & Associates, Inc.
$125
Clovis Oncology, Inc.
$116
Merck Sharp & Dohme Corporation
$109
Amgen Inc.
$109
PFIZER INC.
$105
BeiGene USA, Inc.
$96
Merck Sharp & Dohme LLC
$58
Boehringer Ingelheim Pharmaceuticals, Inc.
$55
Bayer HealthCare Pharmaceuticals Inc.
$53
Ipsen Biopharmaceuticals, Inc
$51
Takeda Pharmaceuticals U.S.A., Inc.
$51
Foundation Medicine, Inc.
$47
Kite Pharma, Inc.
$47
Adaptive Biotechnologies Corporation
$46
EISAI INC.
$41
Exelixis Inc.
$33
Sirtex Medical Inc
$33
EMD Serono, Inc.
$32
Eisai Inc.
$31
Karyopharm Therapeutics Inc.
$31
Jazz Pharmaceuticals Inc.
$25
E.R. Squibb & Sons, L.L.C.
$25
AMAG Pharmaceuticals, Inc.
$25
Cumberland Pharmaceuticals, Inc.
$24
Teva Pharmaceuticals USA, Inc.
$23
Sobi, Inc
$19
Alexion Pharmaceuticals, Inc.
$17
GENZYME CORPORATION
$17
Seagen Inc.
$16
Aurobindo Pharma USA, Inc.
$16
Janssen Pharmaceuticals, Inc
$15
Rigel Pharmaceuticals, Inc.
$14
Gilead Sciences, Inc.
$12
Genentech USA, Inc.
$12
Top 3 companies account for 52.1% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ALIMTA · BENDEKA · BOSULIF · BRUKINSA · Bavencio · CABLIVI · CALQUENCE · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · ERBITUX · ERLEADA · Enhertu · FERAHEME · FOUNDATIONONE · GILOTRIF · GORE VIABAHN VBX Balloon Expandable Endo · Halaven · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Inrebic · JAKAFI · KEYTRUDA · KISQALI · Kyprolis · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MVASI · Nexavar · Nplate · OPDIVO · PIQRAY · PROMACTA · Pomalyst · REBLOZYL · Revlimid · Rubraca · SANCUSO · SIR-Spheres Microspheres · SOMATULINE DEPOT · TAGRISSO · TUKYSA · Tavalisse · ULTOMIRIS · VERZENIO · XALKORI · XARELTO · XGEVA · XPOVIO · Xospata · Yescarta · ZEPZELCA · Zevalin · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (52%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
176
Per 100K population
51.9
County median income
$110,631
Nearest hospital
GOOD SAMARITAN HOSPITAL OF SUFFERN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Farooqi is a mixed practice specialist, with above-average Medicare volume (top 22% in NY), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Farooqi experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Farooqi performed 4,800 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Farooqi receive payments from pharmaceutical companies?
Yes. Dr. Farooqi received a total of $5,385 from 42 companies across 144 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Farooqi's costs compare to other hematology & oncology specialists in Suffern?
Dr. Farooqi's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Farooqi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Suffern
Browse hematology & oncology specialists in Suffern ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology